D-0482-2022 Class II Terminated

Recalled by Ultra Seal Corporation — New Paltz, NY

FDA drug recall D-0482-2022 was initiated by Ultra Seal Corporation on Jan 24, 2022 and is designated Class II. Reason for recall: cGMP deviations The recall status is terminated (terminated Oct 16, 2023). Affected quantity: 5,107,565 packets.

Recall details

Product Type
Drugs
Report Date
Feb 9, 2022
Initiation Date
Jan 24, 2022
Termination Date
Oct 16, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,107,565 packets

Product description

Backache & Muscle Relief (acetaminophen 250 mg, magnesium salicylate-tetrahydrate 290mg, caffeine 50 mg) 2 tablets per packet, Mfd. for First Aid Direct, Mason, OH 45040, NDC 42961-111-832

Reason for recall

cGMP deviations

Distribution pattern

Nationwide within the United States

Code information

Lot #: K9770, AK9770 Exp. Date 08/2022; AK9958, K9958 Exp. Date 12/2022; AK9717, Exp. Date 07/2022; AK9522, AK9641 , Exp. Date 03/2022; AK9817, Exp. Date 09/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0482-2022
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Ultra Seal Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0482-2022. Report a data issue: hello@regdatalab.com.